期刊文献+

3-溴丙酮酸对人宫颈癌HeLa细胞增殖的抑制作用 被引量:4

Inhibition of 3-bromopyruvate on proliferation of human cervical cancer HeLa cells
暂未订购
导出
摘要 目的:研究3-溴丙酮酸(3-BrPA)对宫颈癌HeLa细胞生长及增殖的影响。方法:HeLa细胞经不同浓度3-BrPA作用后,用四甲基偶氮唑蓝(MTT)检测HeLa细胞的增殖情况,倒置显微镜及荧光显微镜观察细胞形态,流式细胞仪检测细胞周期分布及坏死或凋亡情况。结果:经3-BrPA作用一段时间后:MTT检测发现在一定浓度范围内(50-200)μmol/L对HeLa细胞增殖的抑制作用呈浓度依赖性,与对照组比较,各浓度组差异均有统计学意义(P<0.01)。倒置显微镜下可见HeLa细胞生长稀疏,细胞透亮度下降,细胞皱缩、破碎。Hoechst染色后荧光显微镜下呈现典型的凋亡核固缩表现。细胞周期分析结果表明,可诱导HeLa细胞G2/M期阻滞(P<0.01)。流式细胞仪及荧光显微镜观察表明3-BrPA可诱导细胞坏死和凋亡(P<0.01)。结论:3-BrPA对宫颈癌细胞增殖有显著抑制作用。 Objective: To observe the inhibitory effect of 3 -bromopyruvate (3 - BrPA) on the cell proliferation of HeLa human cervical cancer cell line. Methods: The HeLa cells were exposed to 3 - bromopyruvate environment with different concentrations and different times, then cell growth was measured by MrIT, the cell cycle distribution and apoptotic or necrotic cell death were detected with flow cytometry. The morphologie changes of HeLa cells were ob- served with convert light microscopy and fluorescent staining. Results:3 -bromopyruvate ( 〉 50p^mo]/L) significantly inhibited the proliferation of HeLa cells in a does -dependent manner, induced GJM phase arrest(P 〈 0.01 ), cell necrosis and apoptosis (P 〈0.01 ). The HeLa cells were treated with 3 -bromopyruvate for 24h, convert light mi- croscopy showed cell growth was sparse, clarity cytoplasm decreased and dead cell increased. Conclusion: 3 - bro: mopyruvate can efficiently inhibit the proliferation of Hela cells.
出处 《现代肿瘤医学》 CAS 2012年第5期921-924,共4页 Journal of Modern Oncology
关键词 3-BrPA HELA细胞 增殖 凋亡 坏死 3 - bromopyruvate HeLa cells proliferation necrosis apoptosis
  • 相关文献

参考文献1

二级参考文献22

  • 1Baselga J,Mendelsohn J.The epidermal growth factor receptor as a target for therapy in breast carcinoma.Breast Cancer Res Treat 1994; 29:127-138.
  • 2Bange J,Zwick E,Ullrich A.Molecular targets for breast cancer therapy and prevention.Nat Med 2001; 7:548-552.
  • 3Chopin V,ToiUon RA,Jouy N,Le Bourtfis X.p21 (WAF1/CIP1) is dispensable for GI arrest,but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells.Oncogene 2004; 23:21-29.
  • 4Nelson K.3-bromopyruvate kills cancer cells in animals.Lancet Oncol 2002; 3:524-524.
  • 5Geschwind JF,Ko YH,Torbenson MS,Magee C,Pedersen PL.Novel therapy for liver cancer:direct intraarterial injection of a potent inhibitor of ATP production.Cancer Res 2002; 62:3909-3913.
  • 6Pedersen PL.The cancer cell's "power plants" as promising therapeutic targets:an overview.J Bioenerg Biomembr 2007; 39:1-12.
  • 7Ko YH,Pedersen PL,Geschwind JF.Glucose catabolism in the rabbit VX2 tumor model for liver cancer:characterization and targeting hexokinase.Cancer Lett 2001; 173:83-91
  • 8Foublster V,Writer E Energy blocker to treat liver cancer.Drug Discov Today 2002; 7:934-935
  • 9Gwak GY,Yoon JH,Kim KM,Lee HS,Chung JW,Gores GJ.Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase Ⅱ expression.J Hepatol 2005; 42:358-364
  • 10Ko YH,Smith BL,Wang Y,Pomper MG,Rini DA,Torbenson MS,et al.Advanced cancers:eradication in all cases using 3-bromopyruvate therapy to deplete ATP.Biochem Biophys Res Commun 2004; 324:269-275

共引文献12

同被引文献32

  • 1Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203[J].J Clin Oncol, 2006, 24: 4620-4625.
  • 2De Paoli A, Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer New treatment perspectives[J].Tumori, 2004, 90: 373-378.
  • 3Gwak GY, Yoon JH, Kim KM, et al. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression[J].J Hepatol, 2005, 42: 358-364.
  • 4Vossen JA, Buijs M, Syed L, et al. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on meta stases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization[J].Clin Exp Metastasis, 2008, 25: 811-817.
  • 5Chen Z, Zhang H, Lu W, et al. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate[J].Biochim Biophys Acta, 2009, 1787: 553-560.
  • 6Kim W, Yoon JH, Jeong JM, et al. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma[J].Mol Cancer Ther, 2007, 6: 2554-2562.
  • 7Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res, 2005, 65: 613-621.
  • 8Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production[J].Cancer Res, 2002, 62: 3909-3913.
  • 9Vali M, Liapi E, Kowalski J, et al. Intraarterial therapy with a new potent inhibitor of tumor metabolism(3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer[J].J Vasc Interv Radiol, 2007, 18: 95-101.
  • 10Li Chen,Guo-Sheng Ren,Fan Li,Shan-Quan Sun.Expression of Livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma[J].World Journal of Gastroenterology,2008,14(37):5749-5754. 被引量:41

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部